Hemophilia B News and Research

RSS
New $8.5M research grant aims to address patients affected by severe hemophilia A

New $8.5M research grant aims to address patients affected by severe hemophilia A

Women suffering from blood clots can safely take hormone replacement therapy with anticoagulants

Women suffering from blood clots can safely take hormone replacement therapy with anticoagulants

Baxalta announces initial results from ADYNOVATE Phase 3 trial for treatment of hemophilia patients

Baxalta announces initial results from ADYNOVATE Phase 3 trial for treatment of hemophilia patients

CSL submits rIX-FP new drug application to Japan's Pharmaceuticals and Medical Devices Agency

CSL submits rIX-FP new drug application to Japan's Pharmaceuticals and Medical Devices Agency

FDA updates blood donor deferral recommendations to help ensure continued safety of blood supply

FDA updates blood donor deferral recommendations to help ensure continued safety of blood supply

TSRI-led study shows how different drugs regulate protein linked to asthma, obesity and diabetes

TSRI-led study shows how different drugs regulate protein linked to asthma, obesity and diabetes

INP achieves 80% survival rate in acute lymphoblastic leukemia patients

INP achieves 80% survival rate in acute lymphoblastic leukemia patients

Adynovate approved for patients with Hemophilia A

Adynovate approved for patients with Hemophilia A

St. Jude and Scripps Research Institute scientists help launch Human Dark Proteome Initiative

St. Jude and Scripps Research Institute scientists help launch Human Dark Proteome Initiative

Rice scientists solve long-standing mystery about hemophilia protein

Rice scientists solve long-standing mystery about hemophilia protein

New study from TSRI and Salk points to cause of debilitating nerve disease

New study from TSRI and Salk points to cause of debilitating nerve disease

New genetic discovery could lead to better treatment for X-linked diseases

New genetic discovery could lead to better treatment for X-linked diseases

Interim data from long-term extension Tecfidera® (dimethyl fumarate) study

Interim data from long-term extension Tecfidera® (dimethyl fumarate) study

Promising drug candidate for chronic intractable itch

Promising drug candidate for chronic intractable itch

Shire and Sangamo revise agreement to expedite development of ZFP Therapeutics for Huntington's disease, hemophilia A and B

Shire and Sangamo revise agreement to expedite development of ZFP Therapeutics for Huntington's disease, hemophilia A and B

First patient enrolled in CSL Behring's rVIIa-FP Phase II/III study to treat patients with hemophilia A or B with inhibitors

First patient enrolled in CSL Behring's rVIIa-FP Phase II/III study to treat patients with hemophilia A or B with inhibitors

New technology advances genome engineering

New technology advances genome engineering

New analysis examines pharmacy expenditures for publicly insured children with serious chronic illness

New analysis examines pharmacy expenditures for publicly insured children with serious chronic illness

Researchers find way to reverse clotting factor deficiency that triggers hemophilia A

Researchers find way to reverse clotting factor deficiency that triggers hemophilia A

Novo Nordisk presents new data detailing the impact of hemophilia on patients, caregivers

Novo Nordisk presents new data detailing the impact of hemophilia on patients, caregivers